139 related articles for article (PubMed ID: 8578262)
1. Complications of invasive, urodynamic examinations and prostate biopsies in patients with benign prostatic hyperplasia.
Berge V; Eri LM; Tveter KJ
Scand J Urol Nephrol Suppl; 1995; 172():95-8. PubMed ID: 8578262
[TBL] [Abstract][Full Text] [Related]
2. Infectious complications after instrumentation of urinary tract.
Madsen PO; Larsen EH; Dørflinger T
Urology; 1985 Jul; 26(1 Suppl):15-7. PubMed ID: 4040291
[TBL] [Abstract][Full Text] [Related]
3. Transurethral laser therapy and urinary tract infections.
Miller J; Ludwig M; Schroeder-Printzen I; Schiefer HG; Weidner W
Ann Urol (Paris); 1996; 30(3):131-8. PubMed ID: 8766150
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial prophylaxis in urologic surgery.
Larsen EH; Gasser TC; Madsen PO
Urol Clin North Am; 1986 Nov; 13(4):591-604. PubMed ID: 3535203
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of antibiotic prophylaxis for transrectal prostate biopsy].
Yang L; Hu J; Wei H; Wang L; Zhong H
Zhonghua Wai Ke Za Zhi; 2001 Dec; 39(12):940-2. PubMed ID: 16201177
[TBL] [Abstract][Full Text] [Related]
6. The role of combination medical therapy in benign prostatic hyperplasia.
Greco KA; McVary KT
Int J Impot Res; 2008 Dec; 20 Suppl 3():S33-43. PubMed ID: 19002123
[TBL] [Abstract][Full Text] [Related]
7. Antibiotics prophylaxis for digital-guided transrectal tru-cut needle biopsy of the prostate.
Eke N
West Afr J Med; 2006; 25(4):262-5. PubMed ID: 17402511
[TBL] [Abstract][Full Text] [Related]
8. Complications following combined transrectal ultrasound-guided prostate needle biopsies and transurethral resection of the prostate.
Shen BY; Chang PL; Lee SH; Chen CL; Tsui KH
Arch Androl; 2006; 52(2):123-7. PubMed ID: 16443589
[TBL] [Abstract][Full Text] [Related]
9. Post-instrumentation urinary tract infection.
Omar A; el Serafy F
Chemioterapia; 1987 Jun; 6(2 Suppl):505-6. PubMed ID: 3509483
[No Abstract] [Full Text] [Related]
10. Urodynamics after TURP and HoLEP in urodynamically obstructed patients: are there any differences at 1 year of follow-up?
Rigatti L; Naspro R; Salonia A; Centemero A; Ghezzi M; Guazzoni G; Briganti A; Rigatti P; Montorsi F
Urology; 2006 Jun; 67(6):1193-8. PubMed ID: 16750253
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective study.
Yang Y; Zhao XF; Li HZ; Wang W; Zhang Y; Xiao H; Zhang X
Chin Med J (Engl); 2007 Mar; 120(5):370-4. PubMed ID: 17376305
[TBL] [Abstract][Full Text] [Related]
12. The impact of systematic prostate biopsy on prostate cancer incidence in men with symptomatic benign prostatic hyperplasia undergoing transurethral resection of the prostate.
Ornstein DK; Rao GS; Smith DS; Andriole GL
J Urol; 1997 Mar; 157(3):880-3; discussion 883-4. PubMed ID: 9072591
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater.
Kaplan SA; McConnell JD; Roehrborn CG; Meehan AG; Lee MW; Noble WR; Kusek JW; Nyberg LM;
J Urol; 2006 Jan; 175(1):217-20; discussion 220-1. PubMed ID: 16406915
[TBL] [Abstract][Full Text] [Related]
14. [Value of preoperative urodynamics to the prognosis of transurethral prostate resection for benign prostatic hyperplasia].
Cheng W; Gao JP; Zhang ZY; Ge JP; Xue S
Zhonghua Nan Ke Xue; 2005 Mar; 11(3):207-9. PubMed ID: 15804115
[TBL] [Abstract][Full Text] [Related]
15. Transurethral ethanol injection therapy of benign prostatic hyperplasia: four-year follow-up.
Sakr M; Eid A; Shoukry M; Fayed A
Int J Urol; 2009 Feb; 16(2):196-201. PubMed ID: 19054163
[TBL] [Abstract][Full Text] [Related]
16. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review.
Schumm K; Lam TB
Neurourol Urodyn; 2008; 27(8):738-46. PubMed ID: 18951451
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of high-energy transurethral microwave thermotherapy in alleviating medically refractory urinary retention due to benign prostatic hyperplasia.
Kellner DS; Armenakas NA; Brodherson M; Heyman J; Fracchia JA
Urology; 2004 Oct; 64(4):703-6. PubMed ID: 15491705
[TBL] [Abstract][Full Text] [Related]
19. Correlation between lower urinary tract symptoms and urethral function in benign prostatic hyperplasia.
Nakai H; Yamanishi T; Yasuda K; Kitahara S; Suzuki T
Neurourol Urodyn; 2004; 23(7):618-22. PubMed ID: 15382181
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive assessment of prostatic obstruction in elderly men with lower urinary tract symptoms associated with benign prostatic hyperplasia.
van Venrooij GE; Eckhardt MD; Boon TA
Urology; 2004 Mar; 63(3):476-80. PubMed ID: 15028441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
